2023
DOI: 10.1016/j.ygeno.2022.110554
|View full text |Cite
|
Sign up to set email alerts
|

Pancancer analysis of SKA1 mutation and its association with the diagnosis and prognosis of human cancers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…Another component, SKA1, a member of the kinetochore-associated protein complex, is also a protein involved in proper chromosome segregation (Hanisch et al 2006;Schmidt et al 2012). Pancancer analysis based on publicly available datasets has previously shown that SKA1 is overexpressed in multiple cancers and associated with poor prognosis (Lan et al, 2023). Moreover, in vitro studies have shown that downregulation of SKA1 through shRNA in adenosquamous carcinoma cell lines resulted in cell cycle arrest and apoptosis (Zhang et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Another component, SKA1, a member of the kinetochore-associated protein complex, is also a protein involved in proper chromosome segregation (Hanisch et al 2006;Schmidt et al 2012). Pancancer analysis based on publicly available datasets has previously shown that SKA1 is overexpressed in multiple cancers and associated with poor prognosis (Lan et al, 2023). Moreover, in vitro studies have shown that downregulation of SKA1 through shRNA in adenosquamous carcinoma cell lines resulted in cell cycle arrest and apoptosis (Zhang et al 2013).…”
Section: Discussionmentioning
confidence: 99%
“…Many previous studies have demonstrated the important role of SKA1 in the malignant transformation and progression of multiple cancer types, because this gene can regulate various signaling pathways to affect tumor cell growth and metastasis [6] . Increasing clinical evidence has indicated that poor clinical prognosis, tumor invasion, and metastasis are all connected to increased SKA1 expression in a wide variety of cancers, including non-small cell lung cancer, bladder cancer, and hepatocellular carcinoma [ 7 9 ].…”
mentioning
confidence: 99%